Bausch Seeks to Push Out 2028 Debts in $3.4 Billion Bond Exchange

Junk-rated Bausch Health launched an exchange offer to retire two senior secured notes due in 2028 with a combined $3.4 billion outstanding principal by issuing up to $1.6 billion of 10% senior secured notes maturing in 2032. The transaction pushes out near-term maturities as part of broader efforts to manage a debt load in excess of $20 billion, easing immediate refinancing pressure but at a high coupon that highlights ongoing funding stress and could affect bondholder recoveries and credit spreads.

Analysis

Market structure: The exchange increases effective long-dated supply for weak credits and reduces near-term refinancing volume, favoring liquidity providers and distressed debt specialists who can warehouse 4–10 year duration paper. Expect BB-BB- peers to see modest spread widening (100–300bp) as investors reprice sector tail risk; high-coupon paper will attract yield-hungry buyers but at the cost of higher expected default-adjusted returns.

Risk assessment: Short-term (days–weeks) the primary risk is a failed take-up that forces accelerated liquidity events; watch cash runway and covenant triggers over the next 60–120 days. Medium-term (3–12 months) second-order risks include intercreditor disputes over secured collateral, asset sales under duress that depress recoveries by 10–30%, and volatility spikes in CDS and equity options markets. Tail scenarios (low probability, high impact) include a covenant breach leading to technical default or litigation that freezes restructuring — these would push recoveries materially below current market assumptions.

Trade implications: Tactical trades should size downside protection conservatively (1–3% portfolio) and pursue carry in new 2032-like paper only if yield-to-worst ≥10% and secondary price ≤92; exit on yield compression to ≤7% or positive covenant news. Relative-value: short distressed Bausch paper versus matched-duration investment-grade healthcare bonds to capture spread widening; use ETF overlays (HYG short vs LQD long) if single-name liquidity is poor. Options: buy 6–12 month BHC puts 25% OTM for asymmetric downside with defined cost and use CDS if accessible for larger notional hedges.

Contrarian angle: If the exchange succeeds at scale, near-term default probability falls and long-dated bonds may rally 20–40%, so absolute shorts can be crowded and risky. Historical parallels (post-restructurings that extended maturities) show recoveries can improve if management stabilizes cash flow; therefore opportunistic accumulation of 2030–2035 secured paper at deep yields can outperform if priced below intrinsic recovery-adjusted fair value.

Key Decisions for Investors

• Establish a 1–2% portfolio hedge via Bausch Health (BHC) 6–12 month puts ~25% OTM (or equivalent notional 5y CDS protection); act immediately if BHC equity falls >20% or 5y CDS widens >300bps.
• Allocate up to 1–3% of credit sleeve to newly issued or secondary BHC-like secured paper only if yield-to-worst ≥10% and price ≤92; set a hard exit if yield compresses to ≤7% or issuer posts positive covenant/cash-flow news within 6 months.
• Implement a relative-value pair: short distressed Bausch senior secured bonds (size 1–2% of credit sleeve) and go long matched-duration JNJ senior bonds or LQD equivalent; target spread differential capture of ≥300–400bps and unwind on convergence or after 3–6 months.
• Reduce high-yield healthcare beta by 1–2% (trim HYG/JNK exposure) and redeploy into investment-grade healthcare (increase LQD or JNJ exposure by 1–2%) to lower portfolio default sensitivity while preserving yield pickup.